Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma

Fig. 2

Subgroup expression analysis of CPNE1 in LIHC (UALCAN). a The RNA expression of CPNE1 in normal and LIHC patients. b The mRNA expression of CPNE1 in normal and LIHC patients with different genders. c The mRNA expression of CPNE1 in normal and LIHC patients with different tumor grades. d The mRNA expression of CPNE1 in normal and LIHC patients with different tumor stages. e The mRNA expression of CPNE1 in normal and LIHC patients with different ages. f The mRNA expression of CPNE1 in normal and LIHC patients with different TP‐53 mutant status

Back to article page